Full Breakdown
Racial Disparities in Lung Cancer Treatment Persist
3/7/2026, 12:16:10 AM
Overview of the Study Findings
A recent study published in JAMA Network Open highlights significant racial disparities in lung cancer treatment, particularly affecting Black patients. Researchers from Yale School of Medicine analyzed treatment patterns among over 28,000 Medicare beneficiaries diagnosed with early-stage non-small-cell lung cancer between 2005 and 2019. The findings reveal that Black patients are less likely to receive curative surgical interventions or radiation therapy compared to their white counterparts, a gap that has shown minimal improvement since the early 1990s.
Key Statistics on Treatment Disparities
The study indicates that while the overall use of surgery and radiation therapy has increased over time, Black patients consistently received less aggressive treatment. For instance, between 2005 and 2007, approximately 53% of Black patients underwent surgery, compared to 66% of white patients. By the period from 2015 to 2017, the disparity persisted, with only 44% of Black patients receiving surgery versus 53% of white patients. This trend is particularly concerning given that the study population was limited to Medicare beneficiaries, effectively ruling out insurance coverage as a contributing factor.
Underlying Issues in Access to Treatment
Dr. Olivia Lynch, a postdoctoral research fellow involved in the study, emphasized that the disparities point to deeper access issues, particularly regarding access to surgical services. The research found that when Black patients did receive surgery, they were equally likely to follow treatment guidelines, suggesting that the barriers to treatment occur early in the healthcare process. Furthermore, the introduction of advanced treatments, such as stereotactic body radiation therapy (SBRT), initially saw lower uptake among Black patients, highlighting how new medical advancements can inadvertently exacerbate existing inequities.
Calls for Action and Future Directions
In light of these findings, Dr. Lynch advocates for a shift in focus toward addressing the identified disparities. She stated, “Despite all the effort and attention, we haven’t improved as much as we should have. The next step has to ask why — and what we’re going to do differently.” The study underscores the need for targeted interventions to ensure equitable access to lung cancer treatments for all racial groups.
Conflicting Reports & Gaps
While the study provides a comprehensive overview of treatment disparities, it does not delve into the specific reasons behind the persistent gaps in access to care for Black patients. Further research is needed to explore the systemic barriers that contribute to these disparities and to develop effective strategies for improvement.
Verbatim Quotes
- “If you’re developing cures for cancer, but it’s not getting into the hands of everybody who needs it, then you haven’t succeeded,” — Dr. Olivia Lynch, Yale School of Medicine
- “Despite all the effort and attention, we haven’t improved as much as we should have,” — Dr. Olivia Lynch, Yale School of Medicine
This study serves as a critical reminder of the ongoing challenges in achieving health equity, particularly in cancer treatment, and the urgent need for systemic changes in healthcare delivery.
